alpha1 antitrypsin deficiency therapeutics (University of Cambridge/Apollo Therapeutics)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha1 antitrypsin deficiency therapeutics (University of Cambridge/Apollo Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1-antiproteinase inhibitors
TargetsAlpha-1-antiproteinase
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Therapeutics LtdUniversity Of Cambridge
Active IndicationsN/A
Inactive Indicationsalpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A